首页> 外文OA文献 >Towards a “Sample-In, Answer-Out” Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System
【2h】

Towards a “Sample-In, Answer-Out” Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System

机译:迈向用于核酸提取和扩增的“样品输入,输出”护理点平台:使用HPV E6 / E7 mRNA模型系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The paper presents the development of a “proof-of-principle” hands-free and self-contained diagnostic platform for detection of human papillomavirus (HPV) E6/E7 mRNA in clinical specimens. The automated platform performs chip-based sample preconcentration, nucleic acid extraction, amplification, and real-time fluorescent detection with minimal user interfacing. It consists of two modular prototypes, one for sample preparation and one for amplification and detection; however, a common interface is available to facilitate later integration into one single module. Nucleic acid extracts (n = 28) from cervical cytology specimens extracted on the sample preparation chip were tested using the PreTect HPV-Proofer and achieved an overall detection rate for HPV across all dilutions of 50%–85.7%. A subset of 6 clinical samples extracted on the sample preparation chip module was chosen for complete validation on the NASBA chip module. For 4 of the samples, a 100% amplification for HPV 16 or 33 was obtained at the 1 : 10 dilution for microfluidic channels that filled correctly. The modules of a “sample-in, answer-out” diagnostic platform have been demonstrated from clinical sample input through sample preparation, amplification and final detection.
机译:本文介绍了一种“原理证明”免提且自成一体的诊断平台的开发,该平台可用于检测临床标本中的人乳头瘤病毒(HPV)E6 / E7 mRNA。自动化平台以最少的用户界面执行基于芯片的样品预浓缩,核酸提取,扩增和实时荧光检测。它由两个模块化原型组成,一个用于样品制备,一个用于扩增和检测。但是,可以使用一个公共接口来促进以后集成到一个模块中。使用PreTect HPV-Proofer对从样品制备芯片上提取的宫颈细胞学标本中的核酸提取物(n = 28)进行了测试,所有稀释液中HPV的总检出率为50%–85.7%。选择在样品制备芯片模块上提取的6个临床样品的子集,以在NASBA芯片模块上进行完全验证。对于4个样品,对于正确填充的微流体通道,以1 :: 10的稀释度获得HPV 16或33的100%扩增。从临床样本输入到样本制备,扩增和最终检测,已经演示了“样本输入,答案输出”诊断平台的模块。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号